Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

F Panza, D Seripa, V Solfrizzi, BP Imbimbo… - Expert Opinion on …, 2016 - Taylor & Francis
Introduction: Currently available drugs against Alzheimer's disease (AD) target cholinergic
and glutamatergic neurotransmissions without affecting the underlying disease process …
被引用次数：75 相关文章

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

F Panza, D Seripa, V Solfrizzi, BP Imbimbo… - EXPERT OPINION …, 2016 - publicatt.unicatt.it
Introduction: Currently available drugs against Alzheimer's disease (AD) target cholinergic
and glutamatergic neurotransmissions without affecting the underlying disease process …

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

F Panza, D Seripa, V Solfrizzi, BP Imbimbo… - EXPERT OPINION ON …, 2016 - ricerca.uniba.it
Introduction: Currently available drugs against Alzheimer's disease (AD) target cholinergic
and glutamatergic neurotransmissions without affecting the underlying disease process …

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

F Panza, D Seripa, V Solfrizzi… - Expert opinion on …, 2016 - pubmed.ncbi.nlm.nih.gov
Currently available drugs against Alzheimer's disease (AD) target cholinergic and
glutamatergic neurotransmissions without affecting the underlying disease process. Putative …

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

F Panza, D Seripa, V Solfrizzi, B Imbimbo… - EXPERT OPINION ON …, 2016 - fair.unifg.it
Currently available drugs against Alzheimer's disease (AD) target cholinergic and
glutamatergic neurotransmissions without affecting the underlying disease process. Putative …

Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients.

F Panza, D Seripa, V Solfrizzi, BP Imbimbo… - Expert Opinion on …, 2016 - europepmc.org
Currently available drugs against Alzheimer's disease (AD) target cholinergic and
glutamatergic neurotransmissions without affecting the underlying disease process. Putative …

[引用][C] Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer's disease patients

F Panza, D Seripa, V Solfrizzi, BP Imbimbo… - Expert Opinion on …, 2016 - cir.nii.ac.jp
Emerging drugs to reduce abnormal β-amyloid protein in Alzheimer’s disease patients | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …